OmniStar Financial Group’s Chemours CC Stock Holding History

OmniStar Financial Group’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-9,525	Closed	-$477K	–	100
2017 Q4	$477K	Buy	+9,525	New	+$499K	0.44%	66

Other funds holding CC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

OmniStar Financial Group's CC Position: Q1 2018 in Review

OmniStar Financial Group sold out of Chemours (CC) in Q1 2018, closing a stake of 9,525 shares — an estimated $477K sold.

OmniStar Financial Group first reported a position in CC in Q4 2017 and held it in 1 quarter. The position peaked at $477K in Q4 2017. 546 funds tracked by Wall St. Rank hold CC as of Q1 2018.

OmniStar Financial Group reported no remaining Chemours position as of Q1 2018 after selling out during the quarter.
OmniStar Financial Group sold 9,525 Chemours shares in Q1 2018, an estimated $477K.
OmniStar Financial Group first reported a position in Chemours in Q4 2017 and held it in 1 quarter.
OmniStar Financial Group's Chemours position peaked at $477K in Q4 2017.
546 funds tracked by Wall St. Rank held Chemours as of Q1 2018.

Based on OmniStar Financial Group's 13F filing for Q1 2018, filed 11 May 2018.